These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8565310)

  • 21. Rheumatoid inflammatory T-cell clones express mostly Th1 but also Th2 and mixed (Th0-like) cytokine patterns.
    Quayle AJ; Chomarat P; Miossec P; Kjeldsen-Kragh J; Førre O; Natvig JB
    Scand J Immunol; 1993 Jul; 38(1):75-82. PubMed ID: 8101016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Salivary gland and peripheral blood T helper 1 and 2 cell activity in Sjögren's syndrome compared with non-Sjögren's sicca syndrome.
    van Woerkom JM; Kruize AA; Wenting-van Wijk MJ; Knol E; Bihari IC; Jacobs JW; Bijlsma JW; Lafeber FP; van Roon JA
    Ann Rheum Dis; 2005 Oct; 64(10):1474-9. PubMed ID: 15817659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Common T cell receptor clonotype in lacrimal glands and labial salivary glands from patients with Sjögren's syndrome.
    Matsumoto I; Tsubota K; Satake Y; Kita Y; Matsumura R; Murata H; Namekawa T; Nishioka K; Iwamoto I; Saitoh Y; Sumida T
    J Clin Invest; 1996 Apr; 97(8):1969-77. PubMed ID: 8621782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced expression of programmed death-1 (PD-1)/PD-L1 in salivary glands of patients with Sjögren's syndrome.
    Kobayashi M; Kawano S; Hatachi S; Kurimoto C; Okazaki T; Iwai Y; Honjo T; Tanaka Y; Minato N; Komori T; Maeda S; Kumagai S
    J Rheumatol; 2005 Nov; 32(11):2156-63. PubMed ID: 16265694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Possible function of salivary gland epithelial cells as nonprofessional antigen-presenting cells in the development of Sjögren's syndrome.
    Tsunawaki S; Nakamura S; Ohyama Y; Sasaki M; Ikebe-Hiroki A; Hiraki A; Kadena T; Kawamura E; Kumamaru W; Shinohara M; Shirasuna K
    J Rheumatol; 2002 Sep; 29(9):1884-96. PubMed ID: 12233883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired Interleukin-27-Mediated Control of CD4+ T Cell Function Impact on Ectopic Lymphoid Structure Formation in Patients With Sjögren's Syndrome.
    Lucchesi D; Coleby R; Pontarini E; Prediletto E; Rivellese F; Hill DG; Derrac Soria A; Jones SA; Humphreys IR; Sutcliffe N; Tappuni AR; Pitzalis C; Jones GW; Bombardieri M
    Arthritis Rheumatol; 2020 Sep; 72(9):1559-1570. PubMed ID: 32307922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T cell subpopulations in the labial minor salivary gland histopathologic lesion of Sjögren's syndrome.
    Skopouli FN; Fox PC; Galanopoulou V; Atkinson JC; Jaffe ES; Moutsopoulos HM
    J Rheumatol; 1991 Feb; 18(2):210-4. PubMed ID: 1827160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Lymphocyte subsets in labial salivary gland of Sjogren's syndrome].
    Li X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1993 Apr; 15(2):83-8. PubMed ID: 8242827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single-cell analysis reveals sexually dimorphic repertoires of Interferon-γ and IL-17A producing T cells in salivary glands of Sjögren's syndrome mice.
    Wanchoo A; Voigt A; Sukumaran S; Stewart CM; Bhattacharya I; Nguyen CQ
    Sci Rep; 2017 Oct; 7(1):12512. PubMed ID: 28970488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of sphingosine 1-phosphate in the pathogenesis of Sjögren's syndrome.
    Sekiguchi M; Iwasaki T; Kitano M; Kuno H; Hashimoto N; Kawahito Y; Azuma M; Hla T; Sano H
    J Immunol; 2008 Feb; 180(3):1921-8. PubMed ID: 18209090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Labial salivary gland immunopathology in Sjögren's syndrome.
    Dalavanga YA; Drosos AA; Moutsopoulos HM
    Scand J Rheumatol Suppl; 1986; 61():67-70. PubMed ID: 3473652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunohistochemical study of inflammatory infiltrates in minor salivary glands in Sjögren's syndrome and other autoimmune diseases].
    Tomás S; Coll J; Reth P; Corominas JM
    Med Clin (Barc); 1998 Nov; 111(18):681-6. PubMed ID: 9887430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential cytokine expression and regulatory cells in patients with primary and secondary Sjögren's syndrome.
    Furuzawa-Carballeda J; Sánchez-Guerrero J; Betanzos JL; Enriquez AB; Avila-Casado C; Llorente L; Hernández-Molina G
    Scand J Immunol; 2014 Dec; 80(6):432-40. PubMed ID: 25346207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of MHC class II antigens and other T cell activation antigens on T cells and salivary duct epithelial cells in the salivary gland of cases of Sjögren's syndrome.
    Takaya M; Ichikawa Y; Shimizu H; Uchiyama M; Moriuchi J; Arimori S
    Tokai J Exp Clin Med; 1990 Mar; 15(1):27-33. PubMed ID: 2087703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma-inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjögren's syndrome.
    Ogawa N; Ping L; Zhenjun L; Takada Y; Sugai S
    Arthritis Rheum; 2002 Oct; 46(10):2730-41. PubMed ID: 12384933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of salivary gland epithelial cell injury in Sjogren's syndrome: in vitro assessment of T cell-derived cytokines and Fas protein expression.
    Abu-Helu RF; Dimitriou ID; Kapsogeorgou EK; Moutsopoulos HM; Manoussakis MN
    J Autoimmun; 2001 Sep; 17(2):141-53. PubMed ID: 11591123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of monoclonal antibodies to analyze peripheral blood and salivary gland lymphocyte subsets in Sjögren's syndrome.
    Fox RI; Carstens SA; Fong S; Robinson CA; Howell F; Vaughan JH
    Arthritis Rheum; 1982 Apr; 25(4):419-26. PubMed ID: 6978718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential immunological aberrations in patients with primary and secondary Sjögren's syndrome.
    Kroneld U; Halse AK; Jonsson R; Bremell T; Tarkowski A; Carlsten H
    Scand J Immunol; 1997 Jun; 45(6):698-705. PubMed ID: 9201311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin (IL)-17-producing pathogenic T lymphocytes co-express CD20 and are depleted by rituximab in primary Sjögren's syndrome: a pilot study.
    Alunno A; Carubbi F; Bistoni O; Caterbi S; Bartoloni E; Di Benedetto P; Cipriani P; Giacomelli R; Gerli R
    Clin Exp Immunol; 2016 Jun; 184(3):284-92. PubMed ID: 26814615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Destruction of salivary and lacrimal glands by Th1-polarized reaction in a model of secondary Sjögren's syndrome in lupus-prone female NZB × NZWF(1) mice.
    Hayashi T; Shimoyama N; Mizuno T
    Inflammation; 2012 Apr; 35(2):638-46. PubMed ID: 21786007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.